ArticleJNCI cancer spectrum2022

Immunotherapy Outcomes in Individuals With Non-Small Cell Lung Cancer and Poor Performance Status.

Rajwanth Veluswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.